ArticleJAMA network open2025

Value-Based Pricing of Resmetirom for Metabolic Dysfunction-Associated Steatotic Liver Disease.

Phuc Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.